Given that MMP-9 is also elevated in other pathologic conditions such as inflammation, ischemia, and diabetes, our results suggest that MMP-9–mediated syndecan-1 loss could be a common pathway contributing to endothelial dysfunction across multiple retinal disease contexts. Here, MMP9 is linked to ischemia.